Exagen, Inc. (XGN)
7.58
+0.04
(+0.53%)
USD |
NASDAQ |
Sep 04, 16:00
7.605
+0.02
(+0.33%)
Pre-Market: 20:00
Exagen Total Return Price : 7.58 for Sept. 4, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| September 04, 2026 | 7.58 |
| September 03, 2026 | 7.54 |
| September 02, 2026 | 7.51 |
| September 01, 2026 | 7.12 |
| August 31, 2026 | 7.34 |
| August 28, 2026 | 7.39 |
| August 27, 2026 | 7.52 |
| August 26, 2026 | 7.67 |
| August 25, 2026 | 7.60 |
| August 24, 2026 | 7.65 |
| August 21, 2026 | 7.92 |
| August 20, 2026 | 7.78 |
| August 19, 2026 | 7.43 |
| August 18, 2026 | 6.59 |
| August 17, 2026 | 6.70 |
| August 14, 2026 | 6.66 |
| August 13, 2026 | 6.58 |
| August 12, 2026 | 6.59 |
| August 11, 2026 | 6.77 |
| August 10, 2026 | 6.64 |
| August 07, 2026 | 6.87 |
| August 06, 2026 | 6.59 |
| August 05, 2026 | 6.65 |
| August 04, 2026 | 6.45 |
| August 03, 2026 | 4.68 |
| Date | Value |
|---|---|
| July 31, 2026 | 4.53 |
| July 30, 2026 | 4.67 |
| July 29, 2026 | 4.35 |
| July 28, 2026 | 4.45 |
| July 27, 2026 | 4.40 |
| July 24, 2026 | 4.68 |
| July 23, 2026 | 4.95 |
| July 22, 2026 | 4.94 |
| July 21, 2026 | 4.86 |
| July 20, 2026 | 4.68 |
| July 17, 2026 | 4.39 |
| July 16, 2026 | 4.25 |
| July 15, 2026 | 4.30 |
| July 14, 2026 | 4.09 |
| July 13, 2026 | 4.14 |
| July 10, 2026 | 4.45 |
| July 09, 2026 | 4.62 |
| July 08, 2026 | 4.36 |
| July 07, 2026 | 4.80 |
| July 06, 2026 | 4.40 |
| July 02, 2026 | 4.54 |
| July 01, 2026 | 4.71 |
| June 30, 2026 | 4.65 |
| June 29, 2026 | 4.75 |
| June 26, 2026 | 4.58 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Myriad Genetics, Inc. | 3.19 |
| BioRestorative Therapies, Inc. | 0.148 |
| CareDx, Inc. | 50.88 |
| Natera, Inc. | 328.18 |
| Sera Prognostics, Inc. | 2.02 |